Lobbying

Opio Connect's latest lobbying report covers Q4 2022, at $10K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Opio Connect

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Opio Connect lobbying by quarter
Opio Connect lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$00
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$10K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Drug Enforcement Administration (DEA)1 reports
  • Health & Human Services, Dept of (HHS)1 reports
  • HOUSE OF REPRESENTATIVES1 reports
  • SENATE1 reports

Firms it paid

Firm
Capitol Hill Consulting Group$10K1 quarters

Former officials lobbying for it

Former position
BRIAN SUTTERStaff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02Q4 2022

Lobbying reports

Filed by
23/01/20for Q4 2022Capitol Hill Consulting Group$10K